Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | ESR1 | P03372 | 2/20 | 0.57 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.57 |
| ▸ | TACR2 | P21452 | 2/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.57 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | SHBG | P04278 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.57 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.57 |
| ▸ | HTR2C | P28335 | 1/20 | 0.57 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.57 |
| ▸ | TST | Q16762 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL6856351 | 1.00 | HTR2A (0.57) | HTR2AALDH1A1ESR1ADRA2AADORA3 | |
| Toluene SCHEMBL8592478 | 1.00 | HTR2A (0.57) | HTR2AALDH1A1ESR1ADRA2AADORA3 | |
| Toluene SCHEMBL18334412 | 1.00 | HTR2A (0.57) | HTR2AALDH1A1ESR1ADRA2AADORA3 | |
| Toluene SCHEMBL3864993 | 1.00 | HTR2A (0.57) | HTR2AALDH1A1ESR1ADRA2AADORA3 | |
| Toluene SCHEMBL16863683 | 1.00 | HTR2A (0.57) | HTR2AALDH1A1ESR1ADRA2AADORA3 | |
| Toluene SCHEMBL459639 | 1.00 | HTR2A (0.57) | HTR2AALDH1A1ESR1ADRA2AADORA3 | |
| Toluene SCHEMBL8638308 | 1.00 | HTR2A (0.57) | HTR2AALDH1A1ESR1ADRA2AADORA3 | |
| Toluene SCHEMBL461437 | 1.00 | HTR2A (0.57) | HTR2AALDH1A1ESR1ADRA2AADORA3 | |
| Toluene SCHEMBL3842230 | 1.00 | HTR2A (0.57) | HTR2AALDH1A1ESR1ADRA2AADORA3 | |
| Toluene SCHEMBL1934541 | 1.00 | HTR2A (0.57) | HTR2AALDH1A1ESR1ADRA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11968893-B2 | Electroluminescent device | UDC IRELAND LIMITED (IE) | 2024-04-23 | — | — | US | disclosed |
| CN-116964176-A | Compound, liquid crystal composition, and liquid crystal display element, sensor, liquid crystal lens, optical communication device, and antenna using same | DIC株式会社 | 2023-10-27 | — | — | CN | disclosed |
| US-20220216422-A1 | Electroluminescent Device | UDC IRELAND LTD (IE) | 2022-07-07 | — | — | US | disclosed |
| US-20180269403-A1 | ELECTROLUMINESCENT DEVICE | UDC IRELAND LTD (IE) | 2018-09-20 | — | — | US | disclosed |
| US-9923148-B2 | Electroluminescent device | UDC IRELAND LIMITED (IE) | 2018-03-20 | — | — | US | disclosed |
| US-20170194568-A9 | Electroluminescent Device | UDC IRELAND LIMITED (IE) | 2017-07-06 | — | — | US | disclosed |
| EP-2772483-B1 | 4-AMINOCARBAZOLE COMPOUND AND USE OF SAME | TOSOH CORP (JP) | 2017-03-29 | — | — | EP | disclosed |
| EP-1598879-B1 | LUMINESCENCE DEVICE, DISPLAY APPARATUS AND METAL COORDINATION COMPOUND | CANON KK (JP) | 2015-12-02 | — | — | EP | disclosed |
| US-9172045-B2 | 4-aminocarbazole compound and use thereof | TOSOH CORPORATION (JP) | 2015-10-27 | — | — | US | disclosed |
| US-20140296519-A1 | 4-AMINOCARBAZOLE COMPOUND AND USE THEREOF | TOSOH CORPORATION (JP) | 2014-10-02 | — | — | US | disclosed |
| CN-1019390-B | GLUTARIMIDE ANTIANXIETY AND ARTIHYPERTENSIVE AGENTS | MERRELL DOW PHARMA (US) | 1992-12-09 | — | — | CN | disclosed |
| US-5109006-A | Anorexogenic agents, analgesics, psychological disorders | MERRELL DOW PHARMACEUTICALS INC. (US) | 1992-04-28 | — | — | US | disclosed |
| EP-0416946-A2 | Optically active naphthalene derivative, process for preparation thereof, liquid crystal composition containing the same as effective component, and liquid crystal element using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-03-13 | — | — | EP | disclosed |
| EP-0395390-A1 | Optically active biphenyl derivative, process for preparation thereof, liquid crystal composition containing the same as effective component, and liquid crystal element using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-10-31 | — | — | EP | disclosed |
| EP-0375819-A1 | Novel derivatives of 1,7'-[imidazo-[1,2-a]pyridine]5'-(6'H)ones | MERRELL DOW PHARMACEUTICALS INC. (US) | 1990-07-04 | — | — | EP | disclosed |
| EP-0375536-A1 | Derivatives of 1,7'-(imidazo-(1,2-a)pyridine) 5'-(6'H) ones and process for their preparation | MERRELL DOW PHARMACEUTICALS INC. (US) | 1990-06-27 | — | — | EP | disclosed |
| EP-0170213-B1 | GLUTARIMIDE ANTIANXIETY AND ANTIHYPERTENSIVE AGENTS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1990-01-10 | — | — | EP | disclosed |
| CN-85106560-A | The preparation of glutarimide anxiety and antihypertensive drug | — | 1987-03-18 | — | — | CN | disclosed |
| US-4612312-A | Glutarimide antianxiety and antihypertensive agents | MERRELL DOW PHARMACEUTICALS INC. (US) | 1986-09-16 | — | — | US | disclosed |
| EP-0170213-A1 | Glutarimide antianxiety and antihypertensive agents | MERRELL DOW PHARMACEUTICALS INC. (US) | 1986-02-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180269403-A1 | ELECTROLUMINESCENT DEVICE | PNPO, ODC1, AXL | HTR2A 3056/4885ALDH1A1 436/4885ESR1 805/4885 |
| US-20220216422-A1 | Electroluminescent Device | PNPO, ODC1, AXL | HTR2A 3056/4885ALDH1A1 436/4885ESR1 805/4885 |
| US-20170194568-A9 | Electroluminescent Device | DPYD, PNPO, TYMP | HTR2A 1881/4885ALDH1A1 403/4885ESR1 653/4885 |
| US-11968893-B2 | Electroluminescent device | PNPO, ODC1, AXL | HTR2A 3056/4885ALDH1A1 436/4885ESR1 805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.